NeoPharm CO. LTD Net Asset Quality Index
NeoPharm CO. LTD net asset quality index. NeoPharm CO. LTD (092730) has a Net Asset Quality Index of 90.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩207.38 Billion minus total liabilities of ₩18.97 Billion yields net assets of ₩188.40 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See NeoPharm CO. LTD book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of NeoPharm CO. LTD (2012–2024)
Net asset quality index of NeoPharm CO. LTD from 2012 to 2024. This chart shows how NeoPharm CO. LTD's Net Asset Quality Index has evolved across 11 annual periods from 2012 to 2024. As of September 2025, the index stands at 90.9%, representing net assets of ₩188.40 Billion against total assets of ₩207.38 Billion KRW. Check NeoPharm CO. LTD strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
NeoPharm CO. LTD Net Asset Quality Index by Year (2012–2024)
NeoPharm CO. LTD net asset quality index by year from 2012 to 2024. The table below presents the year-by-year Net Asset Quality Index for NeoPharm CO. LTD from 2012 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 092730 market cap overview.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 91.9% | ₩176.88 Billion | ₩192.44 Billion | ₩15.56 Billion | ▲ +1.7 pp |
| 2023 | 90.2% | ₩160.03 Billion | ₩177.46 Billion | ₩17.43 Billion | ▼ -1.4 pp |
| 2022 | 91.5% | ₩142.21 Billion | ₩155.35 Billion | ₩13.14 Billion | ▲ +0.7 pp |
| 2021 | 90.9% | ₩130.30 Billion | ₩143.41 Billion | ₩13.10 Billion | ▲ +2.3 pp |
| 2020 | 88.5% | ₩117.72 Billion | ₩132.98 Billion | ₩15.26 Billion | ▲ +2.4 pp |
| 2019 | 86.1% | ₩105.69 Billion | ₩122.74 Billion | ₩17.05 Billion | ▲ +4.8 pp |
| 2018 | 81.3% | ₩59.29 Billion | ₩72.93 Billion | ₩13.64 Billion | ▼ -2.6 pp |
| 2017 | 83.9% | ₩47.58 Billion | ₩56.69 Billion | ₩9.11 Billion | ▲ +1.0 pp |
| 2016 | 82.9% | ₩38.57 Billion | ₩46.51 Billion | ₩7.94 Billion | ▲ +2.2 pp |
| 2015 | 80.7% | ₩32.62 Billion | ₩40.41 Billion | ₩7.79 Billion | ▼ -6.9 pp |
| 2012 | 87.6% | ₩29.92 Billion | ₩34.14 Billion | ₩4.22 Billion | — |